Abstract:Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women. Although its cardinal manifestations include hyperandrogenism, oligo/anovulation, and/or polycystic ovarian morphology, PCOS women often display also notable metabolic comorbidities. An array of pathogenic mechanisms have been implicated in the etiology of this heterogeneous endocrine disorder; hyperandrogenism at various developmental periods is proposed as a major driver of the metabolic and reproductive perturbations associated with PCOS. However, the current understanding of the pathophysiology of PCOS-associated metabolic disease is incomplete, and therapeutic strategies used to manage this syndrome's metabolic complications remain limited. Scope of review: This study is a systematic review of the potential etiopathogenic mechanisms of metabolic dysfunction frequently associated with PCOS, with special emphasis on the metabolic impact of androgen excess on different metabolic tissues and the brain. We also briefly summarize the therapeutic approaches currently available to manage metabolic perturbations linked to PCOS, highlighting current weaknesses and future directions. Major conclusions: Androgen excess plays a prominent role in the development of metabolic disturbances associated with PCOS, with a discernible impact on key peripheral metabolic tissues, including the adipose, liver, pancreas, and muscle, and very prominently the brain, contributing to the constellation of metabolic complications of PCOS, from obesity to insulin resistance. However, the current understanding of the pathogenic roles of hyperandrogenism in metabolic dysfunction of PCOS and the underlying mechanisms remain largely incomplete. In addition, the development of more efficient, even personalized therapeutic strategies for the metabolic management of PCOS patients persists as an unmet need that will certainly benefit from a better comprehension of the molecular basis of this heterogeneous syndrome.

Progress in Research on Metabolic Disorders in Patients with PCOS

Advances in Molecular Genetic Study on PCOS

Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome]

Aberrant Expression and DNA Methylation of Lipid Metabolism Genes in PCOS: a New Insight into Its Pathogenesis.

Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

A Molecular and Cellular Review of the Literature

Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome

Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites

Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review

Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)

The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms

Effects of Immune Cells and Cytokines on the Endometrial Immune Microenvironment in Polycystic Ovary Syndrome

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

Research status of polycystic ovary syndrome and endometrial hyperplasia

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Research progress on the mechanism of abnormal endometrial receptivity in women with polycystic ovary syndrome

Life Modifications and PCOS: Old Story But New Tales

Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway

Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota

An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome